Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Eric Black-Maier

Clinical Cardiac Electrophysiology Atlanta, GA Medical Doctor

NPI 1225456775 CMS profile 7230083

95 Collier Rd Nw Ste 6000, Atlanta, GA 30309

Open in the dashboard

General payments

$29,238

99 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Eric Black-Maier of Atlanta, GA is reported in the CMS Open Payments database as having received $29,238 across 99 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 61st percentile of Clinical Cardiac Electrophysiology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

6 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $503 16
2024 General $118 1
2022 General $5,706 33
2021 General $10,553 32
2020 General $11,372 8
2019 General $986 9

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Eric Black-Maier
  • Clinical Cardiac Electrophysiology median
  • Middle half of Clinical Cardiac Electrophysiology
  • National median

In program year 2025, general payments to Eric Black-Maier were reported at $503. Among 3,064 Clinical Cardiac Electrophysiology profiles paid that year, the median was $2,462 and the middle half received between $733 and $7,710.

Show as a table
Year Eric Black-Maier Clinical Cardiac Electrophysiology median Middle half National median
2019 $986 $2,361 $585–$8,260 $163
2020 $11,372 $993 $247–$4,351 $114
2021 $10,553 $1,185 $326–$4,739 $132
2022 $5,706 $2,073 $554–$6,789 $149
2023 $0 $2,568 $759–$8,159 $160
2024 $118 $2,557 $703–$7,403 $164
2025 $503 $2,462 $733–$7,710 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Boston Scientific Corporation $17,356 80 payments
  2. Medtronic Vascular, Inc. $6,307 5 payments
  3. Medtronic, Inc. $5,370 8 payments
  4. ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) $130 2 payments
  5. Baxter Healthcare $34 2 payments
  6. Biosense Webster, Inc. $22 1 payment
  7. Novartis Pharmaceuticals Corporation $20 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Grant $26,250 5 payments
  2. Food and Beverage $1,975 89 payments
  3. Travel and Lodging $654 2 payments
  4. Education $359 3 payments
Products named General payments · program years 2019–2025
  1. GENERAL - BRADY $10,000 2 payments
  2. EMBLEM S-ICD ELECTRODE DELIVERY SYSTEM $5,004 2 payments
  3. General Therapies $832 6 payments
  4. General - Therapies $189 2 payments
  5. Adapta $158 1 payment
  6. EMBLEM $148 4 payments
  7. FARAPULSE $132 4 payments
  8. LifeVest $130 2 payments
  9. Micra $129 2 payments
  10. LUX-Dx Insertable Cardiac Monitor $118 2 payments
  11. Other $1,114 68 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 8 drugs

Part D claims

339

Median for Clinical Cardiac Electrophysiology: 1,090

Drug cost

$45,814

Median for Clinical Cardiac Electrophysiology: $354,841

Branded share of claims

33%

Median for Clinical Cardiac Electrophysiology: 38.3%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Eliquis Apixaban Brand 45 $41,160
Ranolazine Er Ranolazine Brand 52 $2,417
Metoprolol Succinate Generic 123 $1,567
Amiodarone Hcl Generic 29 $192
Metoprolol Tartrate Generic 12 $156
Sotalol Sotalol Hcl Brand 15 $139
Spironolactone Generic 52 $132
Furosemide Generic 11 $50

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 2,573 Part D prescribers listed as Clinical Cardiac Electrophysiology; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 65 billing codes

Paid by Medicare

$113,453

Medicare's payments for the services billed

Medicare patients

1,569

Average age 78

Services billed

2,382

667 women, 902 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Atrial fibrillation 61%
Heart failure 56%
Ischemic heart disease 54%
Chronic kidney disease 44%
Arthritis 43%
Diabetes 33%
Depression 26%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

99 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Clinical Cardiac Electrophysiology in Georgia

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record